Advertisement
U.S. Markets open in 1 hr 4 mins

Akebia Therapeutics, Inc. (AKBA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
1.3700+0.0300 (+2.24%)
At close: 04:00PM EDT
1.4000 +0.03 (+2.19%)
Pre-Market: 08:24AM EDT
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
174,497
194,623
292,484
211,650
294,644
-
Cost of Revenue
65,327
74,149
85,568
150,671
296,477
-
Gross Profit
109,170
120,474
206,916
60,979
-1,833
-
Operating Expense
144,265
166,549
271,762
325,481
375,993
-
Operating Income
-35,095
-46,075
-64,846
-264,502
-377,826
-
Net Non Operating Interest Income Expense
-7,475
-6,032
-15,687
-19,936
-8,871
-
Other Income Expense
2,128
182
-13,693
2,414
1,856
-
Pretax Income
-40,442
-51,925
-94,226
-282,024
-384,841
-
Tax Provision
-
-
0
0
0
-6,631
Net Income Common Stockholders
-40,442
-51,925
-94,226
-282,024
-384,841
-
Diluted NI Available to Com Stockholders
-40,442
-51,925
-94,226
-282,024
-384,841
-
Basic EPS
-0.31
-0.28
-0.51
-1.70
-2.77
-
Diluted EPS
-0.31
-0.28
-0.51
-1.70
-2.77
-
Basic Average Shares
185,984
187,465
182,783
165,950
138,463
-
Diluted Average Shares
185,984
187,465
182,783
165,950
138,463
-
Total Operating Income as Reported
-35,322
-46,256
-80,779
-264,502
-377,826
-
Total Expenses
209,592
240,698
357,330
476,152
672,470
-
Net Income from Continuing & Discontinued Operation
-40,442
-51,925
-94,226
-282,024
-384,841
-
Normalized Income
-41,899
-51,220
-77,387
-282,024
-384,841
-
Interest Income
3,319
-
-
-
-
-
Interest Expense
7,475
6,032
15,687
19,936
8,871
-
Net Interest Income
-7,475
-6,032
-15,687
-19,936
-8,871
-
EBIT
-32,967
-45,893
-78,539
-264,502
-377,826
-
EBITDA
4,629
-8,266
-40,842
-226,532
-343,134
-
Reconciled Cost of Revenue
65,327
74,149
85,568
150,671
296,477
-
Reconciled Depreciation
37,596
37,627
37,697
37,970
34,692
-
Net Income from Continuing Operation Net Minority Interest
-40,442
-51,925
-94,226
-282,024
-384,841
-
Total Unusual Items Excluding Goodwill
1,457
-705
-16,839
0
0
-
Total Unusual Items
1,457
-705
-16,839
0
0
-
Normalized EBITDA
3,172
-7,561
-24,003
-226,532
-343,134
-
Tax Rate for Calcs
0
0
0
0
0
-
Tax Effect of Unusual Items
0
0
0
0
0
-